
Thioridazine NEW
Price | $1520 | $1980 | $2500 |
Package | 25mg | 50mg | 100mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-05-01 |
Product Details
Product Name: Thioridazine | CAS No.: 50-52-2 |
Supply Ability: 10g | Release date: 2025/05/01 |
Product Introduction
Bioactivity
Name | Thioridazine |
Description | Thioridazine is a chemical compound characterized by its potent anti-psychotic and anti-anxiety activities. As an antagonist of the dopamine receptor D2 family proteins, it exhibits a strong inhibitory effect on the PI3K-Akt-mTOR signaling pathways, resulting in anti-angiogenic effects. It also demonstrates significant antiproliferative and apoptosis induction effects in a diverse range of cancer cells, specifically targeting cancer stem cells (CSCs) [1] [2] [3] [4]. |
In vitro | Thioridazine, within a concentration range of 0.01-100 μM over 48 hours, diminishes the viability of NCI-N87 and AGS gastric cancer cells in a concentration-dependent manner, as well as cervical (HeLa, Caski, and C33A) and endometrial (HEC-1-A and KLE) cancer cells at a concentration of 15 μM over 24 hours. At concentrations of 1-15 μM and durations of 24-48 hours, it triggers death in gastric cancer cells via the mitochondrial apoptosis pathway. Moreover, a 15 μM concentration of Thioridazine over 24 hours interferes with the PI3K/Akt signaling pathway, leading to G1 cell cycle arrest in cervical and endometrial cancer cells. It also effectively suppresses the proliferation of both antibiotic-sensitive and multidrug-resistant A. baumannii strains. Through cell viability assays and Western blot analyses, it has been demonstrated to induce cytotoxicity in gastric cancer cells by downregulating apoptosis-related proteins, including caspase-9, caspase-8, and caspase-3 precursors. |
In vivo | Thioridazine, administered intraperitoneally (i.p.) at a dosage of 25 mg/kg every three days over a span of three weeks, significantly extends the lifespan of tumor-afflicted mice while diminishing the population of pluripotent embryonal carcinoma (EC) cells within the tumors [5]. Additionally, at doses ranging from 1.0 to 5.0 mg/kg administered subcutaneously (s.c.), Thioridazine effectively mitigates oral behavior and specifically inhibits repetitive head bobbing [1]. In studies using Nude and Rag2KO mice injected with iPS cells or NT2D1 cells [5], this treatment regimen not only reduced the presence of OCT4-expressing cells in malignant teratocarcinomas but also increased the survival rates of the tumor-bearing mice, without impacting fertility. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$1.10/1g |
VIP5Y
|
Dideu Industries Group Limited
|
2021-07-23 | |
$15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-06-27 | ||
$9.80/1.8KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-09 | |
$20.00/1KG |
Hubei XinRunde Chemical Co., Ltd.
|
2018-03-10 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY